Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Non-Current Debt: 2013-2021

Historic Non-Current Debt for Veracyte (VCYT) over the last 8 years, with Sep 2021 value amounting to $1.1 million.

  • Veracyte's Non-Current Debt rose 42.20% to $1.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.1 million, marking a year-over-year increase of 42.20%. This contributed to the annual value of $810,000 for FY2020, which is 16.71% up from last year.
  • As of Q3 2021, Veracyte's Non-Current Debt stood at $1.1 million, which was up 17.23% from $917,000 recorded in Q2 2021.
  • Veracyte's 5-year Non-Current Debt high stood at $25.2 million for Q3 2018, and its period low was $585,000 during Q2 2019.
  • In the last 3 years, Veracyte's Non-Current Debt had a median value of $801,000 in 2020 and averaged $1.9 million.
  • Per our database at Business Quant, Veracyte's Non-Current Debt crashed by 97.67% in 2019 and then skyrocketed by 42.20% in 2021.
  • Veracyte's Non-Current Debt (Quarterly) stood at $24.9 million in 2017, then decreased by 4.06% to $23.9 million in 2018, then crashed by 97.10% to $694,000 in 2019, then grew by 16.71% to $810,000 in 2020, then skyrocketed by 42.20% to $1.1 million in 2021.
  • Its Non-Current Debt stands at $1.1 million for Q3 2021, versus $917,000 for Q2 2021 and $863,000 for Q1 2021.